527 related articles for article (PubMed ID: 11913222)
21. Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors.
Maekawa A; Kanaoka Y; Xing W; Austen KF
Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16695-700. PubMed ID: 18931305
[TBL] [Abstract][Full Text] [Related]
22. Effects of synthetic peptido-leukotrienes on bone resorption in vitro.
Garcia C; Qiao M; Chen D; Kirchen M; Gallwitz W; Mundy GR; Bonewald LF
J Bone Miner Res; 1996 Apr; 11(4):521-9. PubMed ID: 8992883
[TBL] [Abstract][Full Text] [Related]
23. Expression of CysLT2 receptors in asthma lung, and their possible role in bronchoconstriction.
Sekioka T; Kadode M; Fujii M; Kawabata K; Abe T; Horiba M; Kohno S; Nabe T
Allergol Int; 2015 Oct; 64(4):351-8. PubMed ID: 26433531
[TBL] [Abstract][Full Text] [Related]
24. Involvement of cysteinyl leukotriene receptors in angiogenesis in rat thoracic aortic rings.
Xu L; Zhang L; Liu L; Fang S; Lu Y; Wei E; Zhang W
Pharmazie; 2010 Oct; 65(10):750-4. PubMed ID: 21105577
[TBL] [Abstract][Full Text] [Related]
25. BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypes.
Tudhope SR; Cuthbert NJ; Abram TS; Jennings MA; Maxey RJ; Thompson AM; Norman P; Gardiner PJ
Eur J Pharmacol; 1994 Nov; 264(3):317-23. PubMed ID: 7698171
[TBL] [Abstract][Full Text] [Related]
26. Cysteinyl leukotriene D4 induced vascular smooth muscle cell proliferation: a possible role in myointimal hyperplasia.
Porreca E; Di Febbo C; Di Sciullo A; Angelucci D; Nasuti M; Vitullo P; Reale M; Conti P; Cuccurullo F; Poggi A
Thromb Haemost; 1996 Jul; 76(1):99-104. PubMed ID: 8819260
[TBL] [Abstract][Full Text] [Related]
27. Functional characteristics of cysteinyl-leukotriene receptor subtypes.
Bäck M
Life Sci; 2002 Jun; 71(6):611-22. PubMed ID: 12072150
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological profile of the novel, potent and selective peptide leukotriene antagonist (E)-2,2-diethyl-3'-[2-[2-(4-isopropyl)thiazolyl]ethenyl]succinanilic acid.
Yamada N; Yamada K; Takahashi K; Nakao E; Kadowaki S; Umezu K
Arzneimittelforschung; 1994 Jun; 44(6):749-53. PubMed ID: 8053974
[TBL] [Abstract][Full Text] [Related]
29. Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand.
Kanaoka Y; Maekawa A; Austen KF
J Biol Chem; 2013 Apr; 288(16):10967-72. PubMed ID: 23504326
[TBL] [Abstract][Full Text] [Related]
30. A second cysteinyl leukotriene receptor in human lung.
Labat C; Ortiz JL; Norel X; Gorenne I; Verley J; Abram TS; Cuthbert NJ; Tudhope SR; Norman P; Gardiner P
J Pharmacol Exp Ther; 1992 Nov; 263(2):800-5. PubMed ID: 1331415
[TBL] [Abstract][Full Text] [Related]
31. Staurosporine inhibits the effects of leukotrienes C4 and D4 in isolated guinea pig heart and trachea.
Schäfer S; Walland A
Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):469-76. PubMed ID: 8577209
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the human cysteinyl leukotriene 2 receptor.
Heise CE; O'Dowd BF; Figueroa DJ; Sawyer N; Nguyen T; Im DS; Stocco R; Bellefeuille JN; Abramovitz M; Cheng R; Williams DL; Zeng Z; Liu Q; Ma L; Clements MK; Coulombe N; Liu Y; Austin CP; George SR; O'Neill GP; Metters KM; Lynch KR; Evans JF
J Biol Chem; 2000 Sep; 275(39):30531-6. PubMed ID: 10851239
[TBL] [Abstract][Full Text] [Related]
33. Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils.
Bandeira-Melo C; Hall JC; Penrose JF; Weller PF
J Allergy Clin Immunol; 2002 Jun; 109(6):975-9. PubMed ID: 12063527
[TBL] [Abstract][Full Text] [Related]
34. Pharmacology of leukotriene receptor antagonists.
Aharony D
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):S214-9. PubMed ID: 9620942
[TBL] [Abstract][Full Text] [Related]
35. Effects of cysteinyl leukotrienes in small human bronchus and antagonist activity of montelukast and its metabolites.
Mechiche H; Naline E; Candenas L; Pinto FM; Birembault P; Advenier C; Devillier P
Clin Exp Allergy; 2003 Jul; 33(7):887-94. PubMed ID: 12859443
[TBL] [Abstract][Full Text] [Related]
36. Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes.
Bäck M; Norel X; Walch L; Gascard J; de Montpreville V; Dahlén S; Brink C
Eur J Pharmacol; 2000 Aug; 401(3):389-95. PubMed ID: 10936498
[TBL] [Abstract][Full Text] [Related]
37. Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1.
Biagioli M; Carino A; Marchianò S; Roselli R; Di Giorgio C; Bordoni M; Fiorucci C; Sepe V; Conflitti P; Limongelli V; Distrutti E; Baldoni M; Zampella A; Fiorucci S
Biochem Pharmacol; 2020 Jul; 177():113987. PubMed ID: 32330496
[TBL] [Abstract][Full Text] [Related]
38. Effect of lobaric acid on cysteinyl-leukotriene formation and contractile activity of guinea pig taenia coli.
Gissurarson SR; Sigurdsson SB; Wagner H; Ingolfsdottir K
J Pharmacol Exp Ther; 1997 Feb; 280(2):770-3. PubMed ID: 9023290
[TBL] [Abstract][Full Text] [Related]
39. Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells.
Thivierge M; Stankova J; Rola-Pleszczynski M
J Allergy Clin Immunol; 2006 May; 117(5):1155-62. PubMed ID: 16675346
[TBL] [Abstract][Full Text] [Related]
40. Guinea pig cysteinyl leukotriene receptor 2 (gpCysLT2) mediates cell proliferation and intracellular calcium mobilization by LTC4 and LTD4.
Ito Y; Hirano M; Umemoto N; Zang L; Wang Z; Oka T; Shimada Y; Nishimura Y; Kurokawa I; Mizutani H; Tanaka T
BMB Rep; 2008 Feb; 41(2):139-45. PubMed ID: 18315950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]